0.00Open0.01Pre Close0 Volume2 Open Interest2.00Strike Price0.00Turnover362.64%IV438.87%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier23DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type0.0868Delta0.4568Gamma37.39Leverage Ratio-0.0012Theta0.0000Rho3.24Eff Leverage0.0002Vega
bluebird bio Stock Discussion
bluebird bio to Present Additional Long-Term Follow-up Data from Gene Therapy Programs in Sickle Cell Disease and Beta-Thalassemia at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition
No comment yet